Save Klisyri as a Last Resort for Actinic Keratosis
July 2021
Klisyri (tirbanibulin) 1% ointment will be a new topical Rx for actinic keratosis.
It’ll be touted as the only 5-day treatment for actinic keratosis...compared to other topicals (Aldara, Efudex, etc) that need to be used for at least 2 to 16 weeks.
But there’s no proof Klisyri works better or has fewer side effects. Plus it costs nearly $1,000 for a 5-day course.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote